James Cloyd

Professor and Director, Center for Orphan Drug Research

University of Minnesota College of Pharmacy

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

James Cloyd is a Professor and Director of the Center for Orphan Drug Research at the College of Pharmacy, University of Minnesota, USA. His research focuses on pharmacological interventions in neurological conditions, including seizure management and innovative therapies for rare disorders such as Gaucher Disease and X-linked adrenoleukodystrophy. Recent publications highlight his expertise in drug repurposing, treatment efficacy in epilepsy, and biomarker assessment in peripheral inflammation.

Articles (7)

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Reena Kartha

University of Minnesota

UNITED STATES

View details

Paul Tuite

Professor

University of Minnesota

UNITED STATES

View details

Lawrence Hirsch

Professor

Yale University

UNITED STATES

View details

Hannah Cock

Professor of Epilepsy & Medical Education

St George’s, University of London

UNITED KINGDOM

View details

Paul J Orchard

University of Minnesota

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

James Cloyd

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher‐level emergency: Consensus recommendations of an expert working group

Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease

Translational and clinical pharmacology considerations in drug repurposing for X‐linked adrenoleukodystrophy—A rare peroxisomal disorder

N-Acetylcysteine Reverses the Mitochondrial Dysfunction Induced by Very Long-Chain Fatty Acids in Murine Oligodendrocyte Model of Adrenoleukodystrophy

Quantitative Assessment of Occipital Metabolic and Energetic Changes in Parkinson’s Patients, Using In Vivo 31P MRS-Based Metabolic Imaging at 7T

Overcoming the challenges of developing an intranasal diazepam rescue therapy for the treatment of seizure clusters

The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus

Collaborators (5)

Reena Kartha

Paul Tuite

Lawrence Hirsch

Hannah Cock

Paul J Orchard

Make your next move.